CF vs SPRO · P/E 12, rev $5.94B vs P/E 9.6, rev $48.0M
CF Industries Holdings Inc (CF) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
CF currently screens at market cap $14.98B and trailing P/E 12.2. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the CF and SPRO stock pages for the full models.
Not investment advice.